{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:52:47Z","timestamp":1774572767115,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["MOP 114913"],"award-info":[{"award-number":["MOP 114913"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bbi.2015.12.009","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T20:52:10Z","timestamp":1450385530000},"page":"54-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Omega-3\/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patients"],"prefix":"10.1016","volume":"53","author":[{"given":"Graham","family":"Mazereeuw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.L.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyn M.","family":"Hillyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul I.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7024-6637","authenticated-orcid":false,"given":"Krista L.","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbi.2015.12.009_b0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/acps.12265","article-title":"Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity","volume":"130","author":"Assies","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.bbi.2015.12.009_b0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. B"},{"issue":"Pt 8","key":"10.1016\/j.bbi.2015.12.009_b0015","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1242\/jcs.114.8.1439","article-title":"Phosphoinositide 3-kinase signalling pathways","volume":"114","author":"Cantrell","year":"2001","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.bbi.2015.12.009_b0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/CRD.0b013e31820e8106","article-title":"Depression and cardiac disease: a review","volume":"19","author":"Celano","year":"2011","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.bbi.2015.12.009_b0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2014.11.005","article-title":"Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"3\u20135","key":"10.1016\/j.bbi.2015.12.009_b0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.plefa.2008.09.003","article-title":"Regulation of brain polyunsaturated fatty acid uptake and turnover","volume":"79","author":"Chen","year":"2008","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"1","key":"10.1016\/j.bbi.2015.12.009_b0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1743-7075-8-25","article-title":"Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans","volume":"8","author":"Chen","year":"2011","journal-title":"Nutr. Metab."},{"issue":"5","key":"10.1016\/j.bbi.2015.12.009_b0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/01.psy.0000233233.48738.22","article-title":"Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report","volume":"68","author":"Davidson","year":"2006","journal-title":"Psychosom. Med."},{"issue":"3","key":"10.1016\/j.bbi.2015.12.009_b0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jpsychires.2012.11.001","article-title":"Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study","volume":"47","author":"Demirkan","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.bbi.2015.12.009_b0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2015.12.009_b0055","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.biopsych.2004.01.021","article-title":"Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes","volume":"55","author":"Frasure-Smith","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2015.12.009_b0060","doi-asserted-by":"crossref","first-page":"e96905","DOI":"10.1371\/journal.pone.0096905","article-title":"Role of omega-3 Fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials","volume":"9","author":"Grosso","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbi.2015.12.009_b0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/jnc.13145","article-title":"A central role for the acid sphingomyelinase\/ceramide system in neurogenesis and major depression","volume":"134","author":"Gulbins","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2015.12.009_b0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2015.12.009_b0075","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clinbiochem.2009.08.016","article-title":"Biological variability of blood omega-3 biomarkers","volume":"43","author":"Harris","year":"2010","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.bbi.2015.12.009_b0080","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ypmed.2004.02.030","article-title":"The Omega-3 index: a new risk factor for death from coronary heart disease?","volume":"39","author":"Harris","year":"2004","journal-title":"Prev. Med."},{"issue":"9","key":"10.1016\/j.bbi.2015.12.009_b0085","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bbalip.2006.05.010","article-title":"Unique molecular signatures of glycerophospholipid species in different rat tissues analyzed by tandem mass spectrometry","volume":"1761","author":"Hicks","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bbi.2015.12.009_b0090","first-page":"207","article-title":"Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids","volume":"12","author":"Kidd","year":"2007","journal-title":"Altern. Med. Rev."},{"issue":"11","key":"10.1016\/j.bbi.2015.12.009_b0095","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.bbalip.2006.08.001","article-title":"Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s","volume":"1761","author":"Kita","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.bbi.2015.12.009_b0100","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00702-005-0374-5","article-title":"High activity of acid sphingomyelinase in major depression","volume":"112","author":"Kornhuber","year":"2005","journal-title":"J. Neural. Transm."},{"issue":"5","key":"10.1016\/j.bbi.2015.12.009_b0105","first-page":"547","article-title":"Depression and prognosis following hospital admission because of acute myocardial infarction","volume":"168","author":"Lauzon","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.bbi.2015.12.009_b0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1476-511X-13-96","article-title":"Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model","volume":"13","author":"Leslie","year":"2014","journal-title":"Lipids Health Dis."},{"issue":"2","key":"10.1016\/j.bbi.2015.12.009_b0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2010.03.018","article-title":"A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression","volume":"68","author":"Lin","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2015.12.009_b0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2012.08.007","article-title":"Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: relationship with interleukin-6","volume":"31","author":"Lotrich","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2015.12.009_b0125","first-page":"2309","article-title":"Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study","volume":"11","author":"Mazereeuw","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbi.2015.12.009_b0130","first-page":"2479","article-title":"A meta-analysis of lipid peroxidation markers in major depression","volume":"11","author":"Mazereeuw","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"4","key":"10.1016\/j.bbi.2015.12.009_b0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12017-010-8121-y","article-title":"Alterations of the sphingolipid pathway in Alzheimer\u2019s disease: new biomarkers and treatment targets?","volume":"12","author":"Mielke","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.bbi.2015.12.009_b0140","series-title":"Standardized Mini Mental State Examination","author":"Molloy","year":"1999"},{"issue":"7","key":"10.1016\/j.bbi.2015.12.009_b0145","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2174\/18715273113129990097","article-title":"Signal transduction abnormalities in suicide: focus on phosphoinositide signaling system","volume":"12","author":"Pandey","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"3","key":"10.1016\/j.bbi.2015.12.009_b0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/archpsyc.58.3.221","article-title":"Depression and cardiac mortality: results from a community-based longitudinal study","volume":"58","author":"Penninx","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbi.2015.12.009_b0155","doi-asserted-by":"crossref","first-page":"21167","DOI":"10.3390\/ijms141021167","article-title":"Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis","volume":"14","author":"Raphael","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2015.12.009_b0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-94-007-6331-9_7","article-title":"Role of phosphatidylinositol 3,4,5-trisphosphate in cell signaling","volume":"991","author":"Riehle","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.bbi.2015.12.009_b0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.plipres.2007.12.004","article-title":"The opposing effects of n-3 and n-6 fatty acids","volume":"47","author":"Schmitz","year":"2008","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.bbi.2015.12.009_b0170","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbalip.2014.08.006","article-title":"Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome","volume":"1851","author":"Serhan","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbi.2015.12.009_b0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: where they are and how they behave","volume":"9","author":"van Meer","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbi.2015.12.009_b0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbi.2015.03.001","article-title":"Characterising acute coronary syndrome-associated depression: let the data speak","volume":"48","author":"Vollmer-Conna","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.bbi.2015.12.009_b0185","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the Hamilton Depression Rating Scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159115300738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159115300738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:42:05Z","timestamp":1760168525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159115300738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":37,"alternative-id":["S0889159115300738"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2015.12.009","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omega-3\/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patients","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2015.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}